Skip to main content

CAPTRUST FINANCIAL ADVISORS

Position in ABT — Abbott Laboratories

CIK 1512024 RALEIGH, NC

Position in ABT

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$46,381,377
-$11,211,303 QoQ
Shares Held
451,752
-1.7% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 52% Shared 0% None 48%

Common Shares in ABT Over Time

Shares Held

Position Value (USD)

Derivatives in ABT

reported options exposure · as of Mar 31, 2026
CallValue
$133,471
CallShares
1,300
PutValue
$1,026,700
PutShares
10,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Mar 31, 2026

CAPTRUST FINANCIAL ADVISORS holds $174,771,393 across 43 Medical Devices names. ABT ranks #2 (26.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 ABT
Abbott Laboratories
This page
451,752 $46,381,377

All Filings in ABT

Export CSV
27 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $46,381,377 451,752
2026-03-31 $133,471 1,300
2026-03-31 $1,026,700 10,000
2025-12-31 $57,592,680 459,675
2025-09-30 $62,512,610 466,721
2025-06-30 $62,622,404 460,425
2025-03-31 $59,469,648 448,320
2024-12-31 $43,651,411 385,920
2024-09-30 $43,045,273 377,557
2024-06-30 $46,478,527 447,296
2024-03-31 $51,639,602 454,334
2023-12-31 $48,594,474 441,487
2023-09-30 $36,737,045 379,319
2023-06-30 $39,557,797 362,849
2023-03-31 $35,504,692 350,629
2022-12-31 $37,443,220 341,044
2022-09-30 $32,542,323 336,320
2022-06-30 $35,156,749 323,578
2022-03-31 $34,435,540 290,939
2021-12-31 $39,098,979 277,810
2021-09-30 $32,552,257 275,563
2021-06-30 $28,556,225 246,323
2021-03-31 $27,340,177 228,139
2020-12-31 $22,250,995 203,224
2020-09-30 $21,371,273 196,373
2020-06-30 $19,147,179 209,419
2020-03-31 $14,790,259 187,432